Coverage
-
February 02, 2015
Myriad Genetics Inc. has settled patent infringement litigation with Ambry Genetics Corp. and Counsyl Inc., agreeing to drop claims filed in Utah federal court alleging that Ambry and others infringed Myriad's patents for BRCA cancer gene testing.
5 other articles on this case.
View all »